Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Seer stock

Own Seer stock in just a few minutes.

Seer, Inc is a biotechnology business based in the US. Seer shares (SEER) are listed on the NASDAQ and all prices are listed in US Dollars. Seer employs 60 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Seer

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SEER – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Seer share price

Use our graph to track the performance of SEER stocks over time.

Seer shares at a glance

Information last updated 2021-04-21.
52-week range$38.37 - $86.55
50-day moving average $49.66
200-day moving average $58.78
Wall St. target price$63.67
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Buy Seer shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Seer stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Seer financials

Revenue TTM $656,000
Gross profit TTM $-18,286,000
Return on assets TTM -7.85%
Return on equity TTM -12.62%
Profit margin 0%
Book value N/A
Market capitalisation $3.1 billion

TTM: trailing 12 months

Shorting Seer shares

There are currently 3.5 million Seer shares held short by investors – that's known as Seer's "short interest". This figure is 29.4% up from 2.7 million last month.

There are a few different ways that this level of interest in shorting Seer shares can be evaluated.

Seer's "short interest ratio" (SIR)

Seer's "short interest ratio" (SIR) is the quantity of Seer shares currently shorted divided by the average quantity of Seer shares traded daily (recently around 705510). Seer's SIR currently stands at 4.9. In other words for every 100,000 Seer shares traded daily on the market, roughly 4900 shares are currently held short.

To gain some more context, you can compare Seer's short interest ratio against those of similar companies.

However Seer's short interest can also be evaluated against the total number of Seer shares, or, against the total number of tradable Seer shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Seer's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Seer shares in existence, roughly 60 shares are currently held short) or 0.0741% of the tradable shares (for every 100,000 tradable Seer shares, roughly 74 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Seer.

Find out more about how you can short Seer stock.

Seer share dividends

We're not expecting Seer to pay a dividend over the next 12 months.

Seer overview

Seer, Inc. , a life sciences company, engages in developing and commercializing products for researchers to unlock biological information. The company develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that provides workflow to make proteomic profiling, and the analysis of the samples needed to characterize the nature of the proteome. It intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. Seer, Inc. has a collaboration agreement with Discovery Life Sciences, LLC. The company was formerly known as Seer Biosciences, Inc.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site